Literature DB >> 29100898

Effectiveness of national and subnational infection prevention and control interventions in high-income and upper-middle-income countries: a systematic review.

Lesley Price1, Jennifer MacDonald2, Lynn Melone2, Tracey Howe2, Paul Flowers2, Kay Currie2, Evonne Curran2, Valerie Ness2, Debbie Waddell2, Sarkis Manoukian2, Agi McFarland2, Claire Kilpatrick3, Julie Storr3, Anthony Twyman3, Benedetta Allegranzi3, Jacqui Reilly2.   

Abstract

Evidence-based guidance for national infection prevention and control (IPC) programmes is needed to support national and global capacity building to reduce health-care-associated infection and antimicrobial resistance. In this systematic review we investigate evidence on the effectiveness of IPC interventions implemented at national or subnational levels to inform the development of WHO guidelines on the core components of national IPC programmes. We searched CENTRAL, CINAHL, Embase, MEDLINE, and WHO IRIS databases for publications between Jan 1, 2000, and April 19, 2017. 29 studies that met the eligibility criteria (ie, economic evaluations, cluster-randomised trials, non-randomised trials, controlled before-and-after studies, and interrupted time-series studies exploring the effective of these interventions) were categorised according to intervention type: multimodal, care bundles, policies, and surveillance, monitoring, and feedback. Evidence of effectiveness was found in all categories but the best quality evidence was on multimodal interventions and surveillance, monitoring, and feedback. We call for improvements in study design, reporting of research, and quality of evidence particularly from low-income countries, to strengthen the uptake and international relevance of IPC interventions.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 29100898     DOI: 10.1016/S1473-3099(17)30479-6

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  7 in total

Review 1.  Epidemiology and burden of sepsis acquired in hospitals and intensive care units: a systematic review and meta-analysis.

Authors:  Robby Markwart; Hiroki Saito; Thomas Harder; Sara Tomczyk; Alessandro Cassini; Carolin Fleischmann-Struzek; Felix Reichert; Tim Eckmanns; Benedetta Allegranzi
Journal:  Intensive Care Med       Date:  2020-06-26       Impact factor: 17.440

2.  Implementation research for the prevention of antimicrobial resistance and healthcare-associated infections; 2017 Geneva infection prevention and control (IPC)-think tank (part 1).

Authors:  Walter Zingg; Julie Storr; Benjamin J Park; Raheelah Ahmad; Carolyn Tarrant; Enrique Castro-Sanchez; Sara Tomczyk; Claire Kilpatrick; Benedetta Allegranzi; Denise Cardo; Didier Pittet
Journal:  Antimicrob Resist Infect Control       Date:  2019-05-28       Impact factor: 4.887

3.  Analysis of the challenges in implementing guidelines to prevent the spread of multidrug-resistant gram-negatives in Europe.

Authors:  Evelina Tacconelli; Michael Buhl; Hilary Humphreys; Veronika Malek; Elisabeth Presterl; Jesús Rodriguez-Baño; Margreet C Vos; Walter Zingg; Nico T Mutters
Journal:  BMJ Open       Date:  2019-05-19       Impact factor: 2.692

4.  Implementation of the infection prevention and control core components at the national level: a global situational analysis.

Authors:  E Tartari; S Tomczyk; D Pires; B Zayed; A P Coutinho Rehse; P Kariyo; V Stempliuk; W Zingg; D Pittet; B Allegranzi
Journal:  J Hosp Infect       Date:  2020-11-30       Impact factor: 3.926

5.  Time for a renewed focus on the role of cleaners in achieving safe health care in low- and middle-income countries.

Authors:  Julie Storr; Claire Kilpatrick; Karen Lee
Journal:  Antimicrob Resist Infect Control       Date:  2021-03-24       Impact factor: 4.887

6.  The status of infection prevention and control structures in Eastern China based on the IPCAF tool of the World Health Organization.

Authors:  Kaiwen Ni; Dingping Jin; Zhe Wu; Liyuan Sun; Qun Lu
Journal:  Antimicrob Resist Infect Control       Date:  2022-03-09       Impact factor: 4.887

7.  Healthcare-associated infections in intensive care units in Taiwan, South Korea, and Japan: recent trends based on national surveillance reports.

Authors:  Cho-Han Chiang; Sung-Ching Pan; Tyan-Shin Yang; Keisuke Matsuda; Hong Bin Kim; Young Hwa Choi; Satoshi Hori; Jann-Tay Wang; Wang-Huei Sheng; Yee-Chun Chen; Feng-Yee Chang; Shan-Chwen Chang
Journal:  Antimicrob Resist Infect Control       Date:  2018-11-07       Impact factor: 4.887

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.